Clinical Trials Browser

Active not recruiting × Neoplasms, Germ Cell and Embryonal × 90 days × Clear all

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms, Seminoma

NCT02574728 2026-03-02

AflacST1502

Brain Neoplasms, Carcinoma, Ependymoma, Histiocytosis, Langerhans-Cell, Medulloblastoma, Neoplasms, Neoplasms, Germ Cell and Embryonal, Neuroblastoma, Pinealoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Rhabdoid Tumor

NCT01049230 2026-02-11

Proton Beam Radiation Therapy for Central Nervous System (CNS) Germ Cell Tumors

Phase NA Active not recruiting

45 enrolled

Neoplasms, Germ Cell and Embryonal

NCT03158064 2026-01-28

Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors

Phase 2 Active not recruiting

30 enrolled

Nonseminomatous germ cell tumor, Dysgerminoma, Neoplasms, Germ Cell and Embryonal, Germinoma, Seminoma

NCT04876456 2026-01-15

A Phase II Trial of Cabozantinib With Patients With Refractory GCTs

Phase 2 Active not recruiting

50 enrolled

Nonseminomatous germ cell tumor, Neoplasms, Germ Cell and Embryonal, Seminoma

Clinical Trials

A Study of miRNA 371 in Patients With Germ Cell Tumors

AflacST1502

Proton Beam Radiation Therapy for Central Nervous System (CNS) Germ Cell Tumors

Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors

A Phase II Trial of Cabozantinib With Patients With Refractory GCTs